Decameal

Decameal
Converts invasive shore crabs into sustainable protein and lipid ingredients for the feed industry.
About
What does Decameal do?
Decameal is a Danish FoodTech company that has developed a patent-pending process to convert invasive shore crabs into sustainable protein and lipid ingredients. These ingredients are primarily targeted for the feed industry, including poultry, aquaculture, and pet food. The company also has plans to extract chitin and chitosan from the shells for higher-value markets. Decameal aims to address the global issue of crab waste and the feed industry's need for sustainable alternatives to soy and fis…
What is Decameal's revenue?
StartupHub estimates Decameal's annual revenue at $4.6M (range $2.5M to $6.2M, 62% confidence), based on comparable companies in the sector.
What is Decameal's valuation?
StartupHub estimates Decameal's effective valuation at $3.3M (range $2.2M to $11.3M, 55% confidence), based on comparable companies in the sector.
How much funding has Decameal raised?
Decameal has raised a total of $700K in funding. The most recent round on record is Seed.
Where is Decameal headquartered?
Decameal is headquartered in Grindsted, Denmark.
When was Decameal founded?
Decameal was founded in 2022.
What industry does Decameal operate in?
Decameal operates in FoodTech, Biotechnology, Sustainable Materials, Animal Feed, Sustainable Ingredients, Aquaculture Feed.
How many employees does Decameal have?
Decameal has approximately 8 people on record.
No comments yet. Be the first to share your take.